|
|
|
|
The outbreak of the eosinophilia-myalgia syndrome in 1989 resulted from the ingestion of a chemical constituent that was associated with specific tryptophan-manufacturing conditions at one company.The chemical constituent represented by peak E may contribute to the pathogenesis of the eosinophilia-myalgia syndrome,or it may be a surrogate for another chemical that induces the syndrome. |
|